Press Releases

Press Releases

September 14, 2022
Surface Oncology to Present Preclinical Data Highlighting the IL-27 Gene Expression Signature in Treatment-Resistant Cancers at the 10th Annual International Cytokine and Interferon Society Meeting
September 7, 2022
Surface Oncology to Participate in the Baird 2022 Global Healthcare Conference
August 24, 2022
Surface Oncology to Participate in the Gilmartin Group Emerging Growth Company Showcase
August 3, 2022
Surface Oncology Reports Financial Results and Business Highlights for Second Quarter 2022
August 1, 2022
Surface Oncology to Participate in the 2022 Wedbush PacGrow Healthcare Conference
June 29, 2022
Surface Oncology Appoints Carsten Brunn to Board of Directors
June 20, 2022
Surface Oncology Announces Publication of New Study Demonstrating the Role of the IL-27 Pathway in Hepatocellular Carcinoma
June 3, 2022
Surface Oncology Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
June 1, 2022
Surface Oncology to Participate in Upcoming Investor Conferences
May 26, 2022
Surface Oncology to Present New SRF388 Clinical Data at 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
Displaying 1 - 10 of 23